Liposyn 20%

NDA 18614, held by Abbott. Safflower Oil.

As of Nov 14, 2026, NDA 18614 (Liposyn 20%), held by Abbott, was first approved by FDA on Oct 26, 1981, with 6 approved supplements and 0 published complete response letters.

First approved: Oct 26, 1981
Review: Standard
Supplements approved: 6
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 7 submissions below

Date	Submission	Status	Documents
Oct 26, 1981	Original applicationNew dosage form · Standard review	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Liposyn 20%20% (20GM/100ML) · injectable;injection	Safflower Oil	Discontinued

All 7 submissions, including labeling and manufacturing supplements


Apr 26, 1996	Supplement 7Labeling	Approved	None posted
Aug 10, 1984	Supplement 11Labeling	Approved	None posted
Feb 27, 1984	Supplement 9Labeling	Approved	None posted
Oct 22, 1982	Supplement 6Labeling	Approved	None posted
Apr 20, 1982	Supplement 2Labeling	Approved	None posted
Mar 8, 1982	Supplement 3Labeling	Approved	None posted
Oct 26, 1981	Original applicationNew dosage form · Standard review	Approved	None posted

Identifiers

Application: NDA 18614
Drugs@FDA: Overview at FDA
Company: Abbott

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters